Publications by authors named "E V Sosa"

This study aimed to adapt evidence-based diabetes self-management education and support (DSMES) into a faith-based (FB) context for Hispanic communities and compare its effectiveness to a faith-placed (FP) approach using the church as a venue for DSMES delivery. A cluster-randomized trial was conducted among adults with type 2 diabetes from predominantly Hispanic churches. The churches were assigned to either the FB Group (nine churches, n = 146) or the FP Group (seven churches, n = 125).

View Article and Find Full Text PDF

Yerba mate (YM, ) is an economically important crop marketed for the elaboration of mate, the third-most widely consumed caffeine-containing infusion worldwide. Here, we report the first genome assembly of this species, which has a total length of 1.06 Gb and contains 53,390 protein-coding genes.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to investigate the experiences of Hispanic adults engaged in a diabetes self-management education and support program at church, focusing on their insights about the intervention approach and delivery.
  • Focus groups with 138 participants from two different church-based intervention groups revealed that the church environment fostered a supportive community and led to positive improvements in diabetes management.
  • The findings indicate that utilizing church settings for diabetes education programs can enhance participation and effectiveness within Hispanic communities, particularly when incorporating faith-based elements.
View Article and Find Full Text PDF

Objective: To assess effects of Healthy Change intervention on maternal perception of her child's body weight (MPCW), maternal feeding style, and obesogenic home environment.

Methods: A randomized control trial was conducted, consisting of two arms: the intervention group received the Healthy Change program, and the control group received the Hygiene and Accident Prevention program. A total of 356 mother-preschool child dyads participated, 182 in the intervention group and 174 in the control group, residing in Mexico and the United States.

View Article and Find Full Text PDF
Article Synopsis
  • - Outcomes for patients with locally advanced head and neck cancer (HNC) are poor, with a 50% five-year survival rate, so a test to detect molecular residual disease (MRD) in blood is essential to identify recurrence risk within the first two years after treatment.
  • - A study involving 325 patients assessed MRD using blood samples collected over time, finding that those with MRD positivity had significantly worse recurrence-free survival rates, particularly in HPV-negative cases.
  • - The developed tissue-agnostic test demonstrated high sensitivity (91%) and specificity (88%) for predicting recurrences as much as 14.9 months before they occurred, validating its effectiveness for monitoring HNC patients post-treatment.
View Article and Find Full Text PDF